Health Care/Hospital

Benda Pharmaceutical Announces Resignation of Board Member

HUBEI PROVINCE, China, June 20 /Xinhua-PRNewswire/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, t...

2008-06-20 04:01 598

WuXi PharmaTech 2007 Annual Report Available Online

SHANGHAI, China, June 19 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has posted its 2007 annual rep...

2008-06-19 21:35 818

Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China

TAIZHOU, Jiangsu Province, China, June 19 /Xinhua-PRNewswire/ -- Shenzhen Beike Biotechnology Co., Ltd. ( http://www.beikebiotech.com ), a worldwide leader in providing safe and effective stem cell applications for medical treatment, has commenced outfitting its 21,500 square foot comprehensive ...

2008-06-19 22:00 606

China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute

HARBIN, China, June 19 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (Amex: CSY) ("China Sky One" or "the Company"), a China-based manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic kit products, announced today that its wholly-owned subsidiary, Har...

2008-06-19 20:00 564

CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).

LOS ANGELES, Calif., June 19 /Xinhua-PRNewswire/ -- Canopus BioPharma, Inc. (OTC: CBIA), has confirmed the efficacy of its oncology candidate, CB1400, as a tumor reducing agent and has also demonstrated the synergistic effect of this drug in combination with both cisplatin and cetuximab (Erbitux...

2008-06-19 20:00 699

CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck

LOS ANGELES, Calif., June 23 /Xinhua-PRNewswire/ -- Canopus BioPharma, Inc. (OTC: CBIA), is pleased to announce that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional t...

2008-06-23 20:00 617

Johnson & Johnson Nordic AB Acquires Amic

Gains Access to In Vitro Diagnostic Technologies in Development for Use in Point-of-Care Settings SOLLENTUNA, Sweden, June 19 /Xinhua-PRNewswire/ -- Johnson & Johnson Nordic AB, a Johnson & Johnson company, today announced the acquisition of Amic, a privately held Swedish developer of in vitr...

2008-06-20 15:27 951

MICARDIS(R)- Based Regimens Help More Patients Achieve Their Blood Pressure Goals

BERLIN, June 19 /Xinhua-PRNewswire/ -- - For non-US Healthcare Media and non-UK Healthcare Media - New Studies Show Benefits of MICARDIS(R) (Telmisartan) in Combination With Amlodipine and Hydrochlorothiazide The results of two new studies of MICARDIS(R) (telmisartan...

2008-06-18 23:30 645

Singapore Reinforces Position as a Global Site for Pharma & Biotech;Biomedical Manufacturing Output Quadruples to Reach US$17 Billion

Sophisticated Infrastructure and Skilled Manpower Support Cutting-Edge Manufacturing Activities SAN DIEGO, June 19 /Xinhua-PRNewswire/ -- Singapore has firmly established itself as a leading manufacturing hub in Asia with its strong track record, sophisticated infrastructure, superior IP pr...

2008-06-19 00:01 420

Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation

LOS ANGELES, Calif., June 18 /Xinhua-PRNewswire/ -- Canopus BioPharma, Inc. (OTC: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer and addiction, today announced the signing of a lic...

2008-06-18 20:00 694

China Sky One Medical, Inc. Obtains SFDA Approval to Produce Four New Drugs

HARBIN, China, June 18 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (Amex: CSY) (“China Sky One” or “the Company”), a China-based manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic kit products, announced today that it has obtained approval fro...

2008-06-18 20:00 537

Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research

Strong Government Support Continues to Draw Top Research Institutes, Talent, and Corporate Labs That Are Looking to Place Strategic Bets for the Future SAN DIEGO, June 17 /Xinhua-PRNewswire/ -- Singapore’s investment of more than US$2.1 billion in the biomedical sciences sector has seeded one...

2008-06-18 00:01 710

Shengtai Pharmaceutical, Inc. Announces Progress of Trial Production and Quality Control Tests at New Glucose Facility

WEIFANG, Shandong, China, June 17 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) (“Shengtai Pharmaceutical” or “the Company”), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today provided an up...

2008-06-17 20:00 648

Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas

BEIJING, June 16 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that the Shanxi Center for Disease Control and Prevention (CDC) ordered 257,100 doses of Healive(R), the inactivated hepatitis A vaccine manufactured by Sinovac. O...

2008-06-17 10:05 674

China Yingxia International, Inc. Appoints Chief Financial Officer

HARBIN, China, June 17 /Xinhua-PRNewswire/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the nutraceutical industry engaged in the development, manufacture and distribution of organic nutritional food products, supplemen...

2008-06-16 00:00 568

China Sky One Medical, Inc. Changes Management Team

HARBIN, China, June 14 /Xinhua-PRNewswire/ -- China Sky One Medical, Inc. (AMEX: CSY; "China Sky" or "the Company"), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic kit products in China, announced today that Mr. Xiaoqing Liao has resigned as a Director, CFO ...

2008-06-14 05:00 595

HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity

Rheumatoid Arthritis is the Leading Cause of Work Disability in Europe PARIS, June 13 /Xinhua-PRNewswire/ -- New data announced today showed that treating patients with early, active rheumatoid arthritis (RA) with Abbott's HUMIRA(R) (adalimumab) and methotrexate (MTX) resulted in an indirec...

2008-06-13 14:00 892

Chindex International, Inc. Quantifies Fourth Quarter Charges

BETHESDA, Md., June 13 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX), an independent American provider of international healthcare services and Western healthcare products in the People's Republic of China, provided the following statement related to charges in the fourth qua...

2008-06-13 04:17 805

Mindray's AS3000(TM) Anesthesia Delivery System Receives U.S. FDA Clearance

SHENZHEN, China, June 13 /Xinhua-PRNewswire/ -- Mindray Medical International Limited (NYSE: MR) ("Mindray"), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (th...

2008-06-13 00:51 681

China Medical Technologies Reports Fourth Quarter and Full Year Financial Results

BEIJING, June 12 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy system...

2008-06-12 19:00 586
1 ... 713714715716717718719 ... 758